Evidence map›Paper›PMID 38474115›Full record

ArticleInternational journal of molecular sciences2024

Bruna Fernandes Carvalho, Gabriela Vilas Bôas Gomez, Juliana Carron, Ligia Traldi Macedo, Gisele Melo Gonçalves, Vinicius de Lima Vazquez, Sergio Vicente Serrano, Gustavo Jacob Lourenço, Carmen Silvia Passos Lima

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Association of Cytotoxic T-Lymphocyte Antigen-4 (International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Bruna Fernandes CarvalhoLaboratory of Cancer Genetics, School of Medical Sciences, University of Campinas, Campinas 13083-888, SP, Brazil.
Gabriela Vilas Bôas GomezLaboratory of Cancer Genetics, School of Medical Sciences, University of Campinas, Campinas 13083-888, SP, Brazil.ORCID 0000-0002-4367-4414
Juliana CarronLaboratory of Cancer Genetics, School of Medical Sciences, University of Campinas, Campinas 13083-888, SP, Brazil.ORCID 0000-0002-1108-6343
Ligia Traldi MacedoLaboratory of Cancer Genetics, School of Medical Sciences, University of Campinas, Campinas 13083-888, SP, Brazil.
Gisele Melo GonçalvesMelanoma and Sarcoma Surgery Department, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.
Vinicius de Lima VazquezMelanoma and Sarcoma Surgery Department, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.
Sergio Vicente SerranoDepartment of Medical Oncology, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.
Gustavo Jacob LourençoLaboratory of Cancer Genetics, School of Medical Sciences, University of Campinas, Campinas 13083-888, SP, Brazil.ORCID 0000-0002-5944-0305
Carmen Silvia Passos LimaLaboratory of Cancer Genetics, School of Medical Sciences, University of Campinas, Campinas 13083-888, SP, Brazil.ORCID 0000-0002-1314-2345
Universidade Estadual de Campinas (UNICAMP) · BRHospital de Câncer de Barretos · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.337514/2019-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/09168-8
6 · The paper itself

Abstract

Regulatory T lymphocytes play a critical role in immune regulation and are involved in the aberrant cell elimination by facilitating tumor necrosis factor connection to the TNFR2 receptor, encoded by the

Indexed as

MelanomaMicroRNAsSkin NeoplasmsAgedGenetic Predisposition to DiseaseGenotypeHumansMiddle AgedPolymorphism, Single NucleotideReceptors, Tumor Necrosis Factor, Type IIMicroRNAsMIRN1271 microRNA, humanReceptors, Tumor Necrosis Factor, Type IITNFRSF1B protein, humanclinicopathological aspectscutaneous melanomasingle nucleotide variantsurvivalTNFRSF1B

Identifiers

PMID38474115
PMCPMC10932403
OpenAlexW4392356223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.